Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Terminated × Dosage Forms × Clear all

Phase

Phase NA 1 Phase 1 1

Status

Completed 3 Unknown 1 Terminated 1 Recruiting 1 Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Interventions

Radiosurgery 22 Magnetic Resonance Spectroscopy 20 Surveys and Questionnaires 18 Radiotherapy 17 Blood Specimen Collection 17 Exercise 15 Radiotherapy, Intensity-Modulated 14 Cyclophosphamide 13 Methods 12 Acupuncture Therapy 12 Early Intervention, Educational 11 Cisplatin 11 Biopsy 11 Surgical Procedures, Operative 10 Standard of Care 10 Interviews as Topic 10 Filgrastim 10 Radiofrequency Ablation 9 Magnetic Resonance Imaging 8 fludarabine phosphate 7 Sorafenib 7 Radiation 7 Granulocyte Colony-Stimulating Factor 7 Educational Status 7 Colonoscopy 7 Brachytherapy 7 X-Rays 6 Therapeutics 6 Sentinel Lymph Node Biopsy 6 Gemcitabine 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02718404 2022-06-30

HIFU-Bone

Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS

Phase NA Terminated

Agnosia

Data powered by HemOnc (CC BY 4.0) Colophon ⚡